Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct;31(10):1324-8.
doi: 10.1038/aps.2010.111. Epub 2010 Sep 13.

Inhibition of iNOS protects endothelial-dependent vasodilation in aged rats

Affiliations

Inhibition of iNOS protects endothelial-dependent vasodilation in aged rats

Jue Tian et al. Acta Pharmacol Sin. 2010 Oct.

Abstract

Aim: To examine whether iNOS contributes to endothelial dysfunction in aged rats.

Methods: Male Sprague Dawley rats were divided into three groups: young rats, aged rats treated with vehicle and aged rats treated with N-[3-(Aminomethyl) benzyl] acetamidine (1400W, 1 mg/kg, ip). Vasorelaxation was measured in isolated thoracic aorta. iNOS expression of thoracic aortic arteries was detected using immunohistochemistry and Western blot. Nitrotyrosine (a marker for peroxynitrite formation) content and expression in thoracic aortic tissue were determined using enzyme linked immunosorbent assay and immunohistochemistry.

Results: Maximal relaxation induced by acetylcholine (10⁻⁹ to 10⁻⁵ mol/L) in the aged rats treated with vehicle was significantly decreased (70%±15%, P<0.01), as compared with the young rats (95%±8%). However, the maximal relaxation induced by acidified NaNO2 (an endothelium-independent vasodilator) had no significant difference between the two groups. Moreover, iNOS and nitrotyrosine expression increased in the vessels of the aged rats. In the aged rats treated with 1400W (a highly selective iNOS inhibitor) nitrotyrosine expression was reduced and acetylcholine-induced vasorelaxation was markedly improved (maximal relaxation was increased to 87%±8%, P<0.05), but the acidified NaNO₂-induced vasorelaxation had no significant change.

Conclusion: Our study demonstrated that inhibition of iNOS by 1400W increased endothelium-dependent vasodilation in aged rats. The mechanism was related with attenuation of peroxynitrite formation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Vasorelaxation responses of isolated thoracic aortic rings to each concentration of acetylcholine (A, ACh, an endothelium-dependent vasodilator) or acidified NaNO2 (B, an endothelium-independent vasodilator). cP<0.01 vs young group; eP<0.05, fP<0.01 vs aging group. n=6−8 rats per group.
Figure 2
Figure 2
Effects of aging and 1400W treatment on vascular inducible nitric oxide synthase (iNOS) immunostaining (A, DAB staining, ×40) and iNOS expression (B, Western blot). cP<0.01 vs young group; eP<0.05 vs aging group. n=7 rats per group.
Figure 3
Figure 3
Effect of 1400W, a selective iNOS inhibitor, on nitrotyrosine (NT) staining (A, DAB staining, ×40) and vascular nitrotyrosine content (B) in aged rats. cP<0.01 vs young group; eP<0.05 vs aging group. n=7 rats per group.

Similar articles

Cited by

References

    1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation. 2003;107:139–46. - PubMed
    1. Lakatta EG, Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease. Circulation. 2003;107:346–54. - PubMed
    1. Lakatta EG. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation. 2003;107:490–7. - PubMed
    1. Sayer AA, Cooper C. The ageing process. Menopause Int. 2000;6:55–65.
    1. Behnke BJ, Delp MD. Aging blunts the dynamics of vasodilation in isolated skeletal muscle resistance vessels. J Appl Physiol. 2010;108:14–20. - PMC - PubMed

Publication types